Literature DB >> 26432401

Combined application of ultrasound and SPECT/CT has incremental value in detecting parathyroid tissue in SHPT patients.

L L Yuan1, Y Kan1, D Q Ma2, J G Yang3.   

Abstract

PURPOSE: The goal of this study is to investigate whether combined application of ultrasound and 99mTc-sestamibi SPECT/CT had the incremental value in accurately detecting parathyroid tissue in patients with SHPT over either method alone. PATIENTS AND METHODS: Sixty patients with SHPT on hemodialysis were evaluated preoperatively with parathyroid 99mTc-sestamibi SPECT/CT scintigraphy and ultrasound prior to parathyroidectomy. The sensitivity, specificity and accuracy of 99mTc-sestamibi SPECT/CT scintigraphy, ultrasound and combined application were determined respectively.
RESULTS: The sensitivity, specificity and accuracy of ultrasound were 81% (155/192), 47% (17/36) and 82% (172/228), respectively. The sensitivity, specificity and accuracy of 99mTc-sestamibi SPECT/CT were 85% (163/192), 58% (21/36) and 89% (184/228) respectively. The accuracy of 99mTc-sestamibi SPECT/CT in the diagnosis of parathyroid tissue in patients with SHPT is significantly higher than that of ultrasound. The sensitivity, specificity and accuracy of combined application of ultrasound and 99mTc-sestamibi SPECT/CT were 93% (178/192), 61% (22/36) and 97% (200/228). The sensitivity, specificity and accuracy of combined application of ultrasound and 99mTc-sestamibi SPECT/CT were higher than those of either ultrasound or 99mTc-sestamibi SPECT/CT.
CONCLUSIONS: The combined application of ultrasound and 99mTc-sestamibi SPECT/CT had incremental value in accurately detecting parathyroid tissue in patients with SHPT over either method alone.
Copyright © 2015 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  99mTc-sestamibi; Chronic kidney disease; SPECT/CT; Secondary hyperparathyroidism; Ultrasound

Mesh:

Substances:

Year:  2015        PMID: 26432401     DOI: 10.1016/j.diii.2015.08.007

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  7 in total

1.  Actual role of color-doppler high-resolution neck ultrasonography in primary hyperparathyroidism: a clinical review and an observational study with a comparison of 99mTc-sestamibi parathyroid scintigraphy.

Authors:  Giovanni Mariano Vitetta; Alberto Ravera; Giovanni Mensa; Luca Fuso; Pierluigi Neri; Alessandro Carriero; Stefano Cirillo
Journal:  J Ultrasound       Date:  2018-10-24

2.  Parathyromatosis type 2 detected by 99mTc-MIBI SPECT/CT.

Authors:  Huixiao Cao; Ming Zeng; Haisheng Fang; Lijun Tang; Wei Liu
Journal:  Gland Surg       Date:  2019-12

3.  Combined Application of Ultrasound and CT Increased Diagnostic Value in Female Patients with Pelvic Masses.

Authors:  Yan Liu; Hui Zhang; Xiaoqian Li; Guiqin Qi
Journal:  Comput Math Methods Med       Date:  2016-10-27       Impact factor: 2.238

4.  Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study.

Authors:  Takahisa Hiramitsu; Toshihide Tomosugi; Manabu Okada; Kenta Futamura; Makoto Tsujita; Norihiko Goto; Shunji Narumi; Yoshihiko Watarai; Yoshihiro Tominaga; Toshihiro Ichimori
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

5.  The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism.

Authors:  Xiaoer Zhang; Wenxin Xu; Tongyi Huang; Jingzhi Huang; Chunyang Zhang; Yutong Zhang; Xiaoyan Xie; Ming Xu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

6.  Parathyroidectomy in chronic kidney disease.

Authors:  Lillian Andrade da Rocha; Murilo Catafesta das Neves; Fabio Luiz de Menezes Montenegro
Journal:  J Bras Nefrol       Date:  2021-12-03

7.  99mTc-MIBI SPECT/CT SCINTIGRAPHY AND ULTRASOUND OF THE ANTERIOR NECK REGION IN DIAGNOSING PARATHYROID GLAND PATHOLOGY IN PATIENTS WITH THYROID NODULES.

Authors:  Vedrana Gladić Nenadić; Ines Šiško Markoš; Marija Punda; Ivan Blažeković; Maja Franceschi; Ana Fröbe; Tomislav Jukić
Journal:  Acta Clin Croat       Date:  2022-02       Impact factor: 0.780

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.